• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Enforcement Report - Week of March 6, 2024

    FDA

    Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine

    HEALTH CANADA

    Enforcement Report- Week of June 30, 2021

    FDA

    Health Canada Issues Recall of Bausch Health`s Mephyton (Phytonadione) Tablets

    HEALTH CANADA

    Health Canada Issues Recall of Bausch Health Canada `s Ultravate

    FDA

    Health Canada Issues Recalls of Bausch Health Canada`s Xerese

    HEALTH CANADA

    Health Canada Issues Recalls of Bausch Health, Canada`s Rifampin

    HEALTH CANADA

    Enforcement Report for Week of February 20, 2019

    FDA

    Enforcement Report - Week of October 31, 2018

    FDA

    Enforcement Report - Week of October 24, 2018

    FDA

    Health Canada Issues Type II Drug Recall of Valeant`s Contrave Tablet

    HEALTH CANADA

    Enforcement Report - Week of July 26, 2017

    FDA

    Enforcement Report - Week of April 26, 2017

    FDA

    Valeant Pharmacueticals Receives FDA Warning Letter

    FDA

    Valeant recalls Fenoglide (fenofibrate) tablets due to Failed Dissolution Specifications

    FDA

    Valeant Pharmaceuticals North America LLC initiates Class II recall of Nifedipine due to failed dissolution specifications

    FDA

    Valeant Pharmaceuticals North America LLC , Ongoing Class II recall of Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14. because of Non-Sterility: Valeant`s laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.